Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Serologic Tests for Threadworm Infection Compared for Accuracy

By LabMedica International staff writers
Posted on 10 Feb 2014
The diagnosis of Strongyloides stercoralis or threadworm infection is hampered by the suboptimal sensitivity of fecal-based tests.

There are several serological methods that are believed to be more sensitive than microscopy, although assessing their accuracy is difficult because of the lack of sensitivity of a fecal-based reference gold standard.

Microbiologists at the Sacro Cuore Hospital (Negra Verona, Italy) and their colleagues assessed the sensitivity and specificity of five serologic tests for S. More...
stercoralis, three in-house and two commercially available, on 399 cryopreserved serum samples. Accuracy was measured using fecal results as the primary reference standard, but also using a composite reference standard based on a combination of tests.

The primary reference standard was direct detection of S. stercoralis larvae in stool, either through microscopy of at least three fecal samples after formol-ether concentration or Baermann, or stool agar/charcoal culture for S. stercoralis. Index serologic tests included three noncommercial tests: immunofluorescence antibody test (IFAT), recombinant Strongyloides antigen (NIE) enzyme-linked immunosorbent assay (NIE-ELISA) and the NIE- luciferase immunoprecipitation systems (NIE-LIPS). The two commercially available tests were the Bordier ELISA (Bordier Affinity Products; Crissier, Switzerland) and the SeroELISA Strongyloides IgG (IVD-ELISA) (IVD Research; Carlsbad, CA, USA).

The most sensitive test was IFAT, with 94.6% sensitivity, followed by IVD-ELISA with 92.3% sensitivity. The most specific test was NIE-LIPS, with specificity at 99.6%, followed by IVD-ELISA at 97.4%. NIE-LIPS did not cross-react with any of the specimens from subjects with other parasitic infections. NIE-LIPS and the two commercial ELISAs approach 100% specificity at a cut off level that maintains equal to or greater than 70% sensitivity.

The authors concluded that NIE-LIPS is the most accurate serologic test for the diagnosis of S. stercoralis infection. IFAT and each of the ELISA tests are sufficiently accurate, above a given cut off, for diagnosis, prevalence studies, and inclusion in clinical trials. IFAT loses sensitivity when gaining specificity at the optimal cut off for inclusion with a titer 1/160. The two commercially available ELISA tests showed reliable results in terms of accuracy and can also be used for inclusion in trials. The study was published on January 9, 2014, in the journal Public Library of Science Neglected Tropical Diseases.

Related Links:

Sacro Cuore Hospital
Bordier Affinity Products 
IVD Research



Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Spinal Fluid Cell Count Control
Spinalscopics
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.